Subcutaneous sumatriptan: association with decreases in postoperative pain and opioid use after elective cranial surgery.

Patel, Kunal S; Laiwalla, Azim N; DiCesare, Jasmine A T; Garrett, Matthew C; Wang, Anthony C

Patel, Kunal S; Laiwalla, Azim N; DiCesare, Jasmine A T; Garrett, Matthew C; Wang, Anthony C.

Afiliación

Patel KS; 1Department of Neurosurgery, University of California, Los Angeles, California; and.
Laiwalla AN; 1Department of Neurosurgery, University of California, Los Angeles, California; and.
DiCesare JAT; 1Department of Neurosurgery, University of California, Los Angeles, California; and.
Garrett MC; 2Department of Neurosurgery, University of Cincinnati, Ohio.
Wang AC; 1Department of Neurosurgery, University of California, Los Angeles, California; and.

J Neurosurg ; : 1-9, 2020 Jan 03.

Article en En | MEDLINE | ID: mdl-31899878

Palabras clave

5-HT = 5-hydroxytryptamine (serotonin); 5-HT(1B/1D) = serotonin receptor; PACU = postanesthesia recovery unit; SAH = subarachnoid hemorrhage; craniotomy; opioid; pain management; sumatriptan

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Neurosurg Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google